Cardiac loading conditions modify the ventricular repolarization in conscious dogs with heart failure.
Changes in myocardial loading conditions influence the ventricular action potential via mechanoelectric feedback, a mechanism impaired in pathology. In vivo the QT interval of the electrocardiogram which reflects the action potential duration allows appropriate determination of its modifications. The effects of changes in cardiac loading conditions (load reduction with trinitrin; volume loading with Plasmion) on regional function and ventricular local electrogram were investigated in conscious dogs before (control) and after 4 weeks of rapid pacing (dilated cardiomyopathy, DCM). In controls both interventions increased heart rate. Trinitrin increased end-diastolic wall thickness (EDWth, P<0.001) and reduced absolute QT interval duration (P<0.05). Plasmion decreased EDWth (P<0.001) and increased left ventricular end diastolic pressure (LVEDP, P<0.001) without QT interval alteration. However, the corrected QT interval was unchanged in both interventions. In DCM, trinitrin did not change the QT interval. Plasmion increased LVEDP (P<0.01) and prolonged QT and corrected QT intervals (P<0.01) despite the tachycardia. In controls the changes in cardiac loading conditions did not modify the QT interval, suggesting intact endogenous regulation of repolarization. The impaired adaptation observed in DCM contributed to an increase in QT interval following volume loading. In this model, a prolonged repolarization after abrupt volume loading may result from enhanced or disclosed mechanoelectric feedback.
Victor
F
F
Department of Cardiology, University Hospital, Rennes, France.
Carré
F
F
Gout
B
B
Jean
J
J
M'Polesha
E
E
Mabo
P
P
Bril
A
A
D000818:Animals; D002302:Cardiac Output / Q000502:physiology; D002303:Cardiac Output, Low / Q000503:physiopathology*; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography; D004594:Electrophysiology; D005780:Gelatin / Q000494:pharmacology; D006321:Heart / Q000503:physiopathology*; D006339:Heart Rate / Q000502:physiology; D006439:Hemodynamics / Q000502:physiology; D005996:Nitroglycerin / Q000494:pharmacology; D010952:Plasma Substitutes / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D016276:Ventricular Function; D016277:Ventricular Function, Left / Q000502:physiology
D010952:Plasma Substitutes; D014665:Vasodilator Agents; C013648:plasmion; D005780:Gelatin; D005996:Nitroglycerin